Health & Safety National After more than 20 years, a major arthritis drug is about to face cheaper competition 6:14pm January 31, 2023 by Sydney Lupkin Share URL copied to clipboard! Play Pause There was an error loading the media player. Copyright 2023 NPR. To see more, visit https://www.npr.org. 300x250 Ad More All Things Considered National British luxury retailer Harrod's fell victim to a cyberattack by Rebecca Rosman National Why Hegseth wants to eliminate the Women, Peace and Security program by Michelle Aslam 300x250 Ad Support quality journalism, like the story above, with your gift right now. Donate
9(MDAxODcyMTgzMDEyMTgxMTY5NjYxN2I4OQ004))